Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Advanced Technologies for Antigen Identification
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Research Articles

  • Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
    Gang Xin, Yao Chen, Paytsar Topchyan, Moujtaba Y. Kasmani, Robert Burns, Peter J. Volberding, Xiaopeng Wu, Alexandra Cohn, Yiliang Chen, Chien-Wei Lin, Ping-Chih Ho, Roy Silverstein, Michael B. Dwinell, Weiguo Cui
    Cancer Immunology Research Apr 2021, 9 (4) 454-469; DOI: 10.1158/2326-6066.CIR-20-0433
  • Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells
    Adam N.R. Cartwright, Shengbao Suo, Soumya Badrinath, Sushil Kumar, Johannes Melms, Adrienne Luoma, Archis Bagati, Assieh Saadatpour, Benjamin Izar, Guo-Cheng Yuan, Kai W. Wucherpfennig
    Cancer Immunology Research Apr 2021, 9 (4) 470-485; DOI: 10.1158/2326-6066.CIR-20-0085
  • Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling
    Elisa Landoni, Giovanni Fucá, Jian Wang, Venkat R. Chirasani, Zhiyuan Yao, Elena Dukhovlinova, Soldano Ferrone, Barbara Savoldo, Lee K. Hong, Peishun Shou, Silvia Musio, Francesco Padelli, Gaetano Finocchiaro, Miriam Droste, Brian Kuhlman, Abdijapar Shamshiev, Serena Pellegatta, Nikolay V. Dokholyan, Gianpietro Dotti
    Cancer Immunology Research Apr 2021, 9 (4) 441-453; DOI: 10.1158/2326-6066.CIR-20-0451
  • DGKA Mediates Resistance to PD-1 Blockade
    Lingyi Fu, Sen Li, WeiWei Xiao, Kuai Yu, Shuo Li, Sujing Yuan, Jianfei Shen, Xingjun Dong, Ziqian Fang, Jianeng Zhang, Siyu Chen, Wende Li, Hua You, Xiaojun Xia, Tiebang Kang, Jing Tan, Gong Chen, An-Kui Yang, YuanHong Gao, Penghui Zhou
    Cancer Immunology Research Apr 2021, 9 (4) 371-385; DOI: 10.1158/2326-6066.CIR-20-0216
  • Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4–Targeted Immunotherapy
    Dana A. Emerson, Annah S. Rolig, William L. Redmond
    Cancer Immunology Research Apr 2021, 9 (4) 430-440; DOI: 10.1158/2326-6066.CIR-20-0338
  • Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance
    Reham Ajina, Zoe X. Malchiodi, Allison A. Fitzgerald, Annie Zuo, Shangzi Wang, Maha Moussa, Connor J. Cooper, Yue Shen, Quentin R. Johnson, Jerry M. Parks, Jeremy C. Smith, Marta Catalfamo, Elana J. Fertig, Sandra A. Jablonski, Louis M. Weiner
    Cancer Immunology Research Apr 2021, 9 (4) 386-400; DOI: 10.1158/2326-6066.CIR-20-0272
  • Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
    Pedro Veliça, Pedro P. Cunha, Nikola Vojnovic, Iosifina Petrina Foskolou, David Bargiela, Milos Gojkovic, Helene Rundqvist, Randall S. Johnson
    Cancer Immunology Research Apr 2021, 9 (4) 401-414; DOI: 10.1158/2326-6066.CIR-20-0561
  • Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
    Mark D. Badeaux, Annah S. Rolig, Giulia Agnello, Danlee Enzler, Melissa J. Kasiewicz, Leslie Priddy, Jason F. Wiggins, Alexander Muir, Mark R. Sullivan, Jessica Van Cleef, Christopher Daige, Matthew G. Vander Heiden, Venkatesh Rajamanickam, James E. Wooldridge, William L. Redmond, Scott W. Rowlinson
    Cancer Immunology Research Apr 2021, 9 (4) 415-429; DOI: 10.1158/2326-6066.CIR-20-0317
  • A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer
    Xiaoli Liu, Jilin Lu, Guanxiong Zhang, Junyan Han, Wei Zhou, Huan Chen, Henghui Zhang, Zhiyun Yang
    Cancer Immunology Research Mar 2021, 9 (3) 337-347; DOI: 10.1158/2326-6066.CIR-20-0616
  • The IKZF1–IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages
    Dimitrios Mougiakakos, Christian Bach, Martin Böttcher, Fabian Beier, Linda Röhner, Andrej Stoll, Michael Rehli, Claudia Gebhard, Christopher Lischer, Martin Eberhardt, Julio Vera, Maike Büttner-Herold, Katrin Bitterer, Heidi Balzer, Magdalena Leffler, Simon Jitschin, Michael Hundemer, Mohamed H.S. Awwad, Martin Busch, Steffen Stenger, Simon Völkl, Christian Schütz, Jan Krönke, Andreas Mackensen, Heiko Bruns
    Cancer Immunology Research Mar 2021, 9 (3) 265-278; DOI: 10.1158/2326-6066.CIR-20-0555

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 78
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement